Winning Health(SZ:300253) Sou Hu Cai Jing·2026-01-15 11:45Core Viewpoint - Wining Health (300253) has announced an expected loss for the year 2025, marking the first annual loss since its listing in 2011, despite a significant stock price increase driven by AI concepts in the market [1][4]. Group 1: Financial Performance - Wining Health's preliminary estimate indicates a negative net profit for 2025, with the final figures to be confirmed in the official annual report [1]. - The company reported a revenue of 1.296 billion yuan for the first three quarters of 2025, a year-on-year decrease of 32.27%, and a net profit of -241 million yuan, a decline of 256.1% [6]. - In 2024, Wining Health's revenue was 2.782 billion yuan, down 12.05% year-on-year, with a net profit of approximately 8.8 million yuan, a decrease of 75.45% [7]. Group 2: Company Background and Leadership Changes - Wining Health is a leading enterprise in China's medical information industry and has been actively expanding into healthcare services since 2015 [4]. - Following the bribery scandal involving the former chairman, Zhou Wei, Liu Ning has taken over as chairman, bringing extensive experience from previous roles in the company and the tech industry [5]. Group 3: Market Context and Challenges - The AI concept has been a hot topic in the A-share market, contributing to a nearly 60% increase in Wining Health's stock price this year [1][4]. - Despite being an early mover in AI healthcare, the company faces challenges related to high investment costs and slow conversion rates [8]. - The urgent task for Wining Health in 2026 will be to find ways to return to profitability under new leadership [9].